Bio Protocol is projected to rise to $0.0498 by 2027, a +70% move from its current price of $0.0267. BIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 30/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/27/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 29 | $0.0252 | $0.0267 | $0.0282 | -0.26% |
| Jul 30 | $0.0245 | $0.0266 | $0.0288 | -0.51% |
| Jul 31 | $0.024 | $0.0265 | $0.0293 | -0.76% |
| Aug 1 | $0.0236 | $0.0265 | $0.0297 | -1.02% |
| Aug 2 | $0.0232 | $0.0264 | $0.03 | -1.27% |
| Aug 3 | $0.0229 | $0.0263 | $0.0303 | -1.52% |
| Aug 4 | $0.0226 | $0.0263 | $0.0305 | -1.77% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0226 | $0.0263 | $0.0305 | -1.77% |
| Week 2 | $0.0208 | $0.0258 | $0.0319 | -3.52% |
| Week 3 | $0.0195 | $0.0253 | $0.0329 | -5.23% |
| Week 4 | $0.0184 | $0.0249 | $0.0336 | -6.91% |
| Week 5 | $0.0174 | $0.0244 | $0.0342 | -8.56% |
| Week 6 | $0.0166 | $0.024 | $0.0347 | -10.19% |
| Week 7 | $0.0158 | $0.0236 | $0.0351 | -11.78% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Its mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP). The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.
The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.
BIO is currently priced at $0.0264, with a market cap of $56.68M and ranked 394 by market cap. Its all-time high was $0.889 and its all-time low was $0.0159. The price action in the near term shows a bearish tone with a 30-day range of $0.0214 to $0.04.
The RSI14 sits at 50, and the SMA50 and SMA200 are both $0.0328. Immediate support is $0.0259 and resistance is $0.0365. The asset exhibits high volatility, with annualized volatility of 100%.
A major floor 39.1% below — a decisive break under it would weaken the trend.
The nearest floor, 3.3% below — buyers have tended to step in here.
The nearest ceiling, 36.5% above — a clean break opens room to run.
A major ceiling 127.5% above — clearing it would confirm fresh momentum.
Key BIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0287 | Sell | $0.0289 | Sell |
| MA 10 | $0.0293 | Sell | $0.0295 | Sell |
| MA 20 | $0.031 | Sell | $0.0304 | Sell |
| MA 50 | $0.0327 | Sell | $0.0319 | Sell |
| MA 100 | $0.0312 | Sell | $0.0328 | Sell |
| MA 200 | $0.0328 | Sell | $0.0398 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.18 | Neutral |
| Stoch RSI (14) | 21.73 | Neutral |
| CCI (20) | -65.20 | Neutral |
| Williams %R (14) | -86.30 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -19.95 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 13.70 | Buy |
| TRIX (15) | -0.40 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 44.25 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 0.03 | Sell |
| ADX (14) | 12.14 | Neutral |
| ATR (14) | 0.00 | Info |
The near-term technical picture remains BEARISH. The RSI14 at 50 gives a neutral reading on momentum, but price momentum is weak. The price sits below the key moving averages, with SMA50 and SMA200 at $0.0328, while current price is near support at $0.0259 and faces resistance at $0.0365.
Over the last 30 days, the price traded in a range from $0.0214 to $0.04.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0161 | $0.0292 | $0.0292 | 0% | Neutral | |
| $0.0361 | $0.0498 | $0.0744 | +70% | Bullish | |
| $0.0332 | $0.0488 | $0.0777 | +67% | Bullish | |
| $0.024 | $0.0372 | $0.0621 | +27% | Bullish | |
| $0.0309 | $0.0502 | $0.0872 | +72% | Bullish | |
| $0.049 | $0.0831 | $0.1496 | +184% | Bullish | |
| $0.0434 | $0.0768 | $0.1425 | +163% | Bullish | |
| $0.0299 | $0.0551 | $0.1051 | +88% | Bullish | |
| $0.0469 | $0.0899 | $0.1758 | +207% | Bullish | |
| $0.0712 | $0.1418 | $0.2838 | +385% | Bullish | |
| $0.043 | $0.0956 | $0.2103 | +227% | Bullish | |
| $0.1122 | $0.2493 | $0.5734 | +752% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.0161 | $0.0292 | $0.0306 | +9.39% |
| August 2026 | $0.0159 | $0.0194 | $0.0246 | -33.78% |
| September 2026 | $0.0172 | $0.0212 | $0.0275 | +9.33% |
| October 2026 | $0.0181 | $0.0226 | $0.0298 | +6.88% |
| November 2026 | $0.0146 | $0.0184 | $0.0247 | -18.48% |
| December 2026 | $0.0137 | $0.0175 | $0.0236 | -5.40% |
Click any year to see its month-by-month BIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BIO price prediction for 2026 points to an average of $0.0292 (low $0.0161, high $0.0292) — a potential gain of 0% on today's $0.0267. A consolidation phase looks the most probable path here.
In 2027, BIO is projected to trade between $0.0361 and $0.0744, averaging $0.0498 — a potential gain of +70% from today's $0.0267. That is up +70% on the projected 2026 average. Momentum favours further upside here.
Bio Protocol's 2028 outlook centres on $0.0488, within a $0.0332 to $0.0777 range. That is -2% versus the projected 2027 average. That marks a +67% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BIO could reach as high as $0.0621, with a base case around $0.0372 and support toward $0.024 — roughly +27% from $0.0267. Momentum favours further upside here.
Expect BIO to range from $0.0309 to $0.0872 through 2030. The $0.0502 average target implies a +72% move from current prices. That is up +35% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The BIO price prediction for 2031 points to an average of $0.0831 (low $0.049, high $0.1496) — a potential gain of +184% on today's $0.0267. Momentum favours further upside here.
In 2032, BIO is projected to trade between $0.0434 and $0.1425, averaging $0.0768 — a potential gain of +163% from today's $0.0267. That is -8% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
Bio Protocol's 2033 outlook centres on $0.0551, within a $0.0299 to $0.1051 range. That is -28% versus the projected 2032 average. That marks a +88% change versus current levels. Momentum favours further upside here.
By 2034, BIO could reach as high as $0.1758, with a base case around $0.0899 and support toward $0.0469 — roughly +207% from $0.0267. Buyers look set to stay in control over this stretch.
Expect BIO to range from $0.0712 to $0.2838 through 2035. The $0.1418 average target implies a +385% move from current prices. That is up +58% on the projected 2034 average. Momentum favours further upside here.
The BIO price prediction for 2040 points to an average of $0.0956 (low $0.043, high $0.2103) — a potential gain of +227% on today's $0.0267. Buyers look set to stay in control over this stretch.
In 2050, BIO is projected to trade between $0.1122 and $0.5734, averaging $0.2493 — a potential gain of +752% from today's $0.0267. That is up +161% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BIO today (≈ 37,406.754313 BIO) could be worth
$9,325
+$8,325 (+833%) by 2050 · US Dollar
Based on the average projected BIO price of $0.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BIOwould be worth at today's price.
$1,000 invested in BIO on Jul 1, 2025 (≈ 19,259.159058 BIO) would be worth
$514.86
-$485.14 (-48.5%) today · 0.51× · US Dollar
Based on a BIO entry price of $0.051923 vs. today's $0.026733.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.030091 | $888.42 | -11.2% |
| 1 month ago | $0.030654 | $872.09 | -12.8% |
| 3 months ago | $0.016734 | $1,597.56 | +59.8% |
| 6 months ago | $0.045896 | $582.47 | -41.8% |
| 1 year ago | $0.051923 | $514.86 | -48.5% |
| All time (1.1y) ago | $0.087759 | $304.62 | -69.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BIO forecast.
Our base-case forecast reaches $0.053 around 2031.
Implied market cap at $0.053: $113.69M
The multi-year forecast shows a bullish trajectory beginning in 2027, with the 2027 average price at $0.0498 and an ROI of 70.3%. The 2028 forecast remains bullish with an average of $0.0488 and ROI 66.8%. The 2030 forecast projects an average of $0.0502 with an ROI of 71.6%.
Looking further out, 2040 is seen at an average of $0.0956 with an ROI of 227%, and 2050 at an average of $0.2493 with an ROI of 752.5%. Across these years, the sentiment is listed as BULLISH. These numbers illustrate a potential long-run upside but remain estimates and are not guarantees, with volatility acknowledged as a risk.
Tap a question to reveal the answer.
The forecast shows an avg price of $0.0502 with an ROI of 71.6%.
Yes. The forecast for 2027 shows a BULLISH sentiment with an avg price of $0.0498 and ROI of 70.3%.
Current price is $0.0264 and market cap is $56.68M; BIO is ranked 394.
All-time high is $0.889 and all-time low is $0.0159.
2040 forecast: avg $0.0956, ROI 227%, sentiment BULLISH. 2050 forecast: avg $0.2493, ROI 752.5%, sentiment BULLISH.
Bio Protocol Community Discussion
0Share your Bio Protocol price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.